FVFanny Vaillant
Fanny Vaillant
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fanny Vaillant has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Alain Tabib
3 shared publicationsBernard Bui-Xuan
3 shared publicationsJacques Descotes
3 shared publicationsLeila Dehina
3 shared publicationsAlejandro Mazzadi
Centre d’Étude et de Recherche Multimodal Et Pluridisciplinaire en Imagerie du vivant (CERMEP), 69 Boulevard Pinel, 69677, Bron cedex, France
2 shared publicationsBenjamin Lauzier
Institut de Cardiologie de Montréal, Laboratoire de Métabolisme Intermédiaire, Montréal, Canada
2 shared publications
Latest Publications
- 1 March 2013
- Published by Elsevier in Resuscitation
- Vol. 84 (3) , 384-390
Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status
- 1 March 2013
- Published by Elsevier in Resuscitation
- Vol. 84 (3) , 384-390
Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status
- 12 May 2011
- Published by Elsevier in Resuscitation
- Vol. 82 (8) , 1092-1099
Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: Role of myocyte structure and myocardial perfusion
- 12 May 2011
- Published by Elsevier in Resuscitation
- Vol. 82 (8) , 1092-1099
Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: Role of myocyte structure and myocardial perfusion
- 31 January 2011
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 3 (1) , 84
256 The metabolic effects of glutamine in the heart beyond anaplerosis: role of the hexosamine biosynthetic pathway
- 31 January 2011
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 3 (1) , 84
256 The metabolic effects of glutamine in the heart beyond anaplerosis: role of the hexosamine biosynthetic pathway